Article
The effect of disease-associated HRPT2 mutations on splicing.
The Journal of endocrinology - 1 Jun 2009
Hahn Michael A, McDonnell Julie, Marsh Deborah J
Abstract excerpt
Mutations in the tumour suppressor HRPT2 occur in patients with parathyroid carcinoma, kidney tumours and Hyperparathyroidism-Jaw Tumour syndrome. Disruption of exonic splicing through mutation of donor/acceptor splice sites or exonic splice enhancer (ESE) sites leads to loss of function of a number of major tumour suppressors including BRCA1, APC and MLH1. Given that the effect of HRPT2 mutations on splicing has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
